<table border="1"><tr><th>Type</th><td><ul><li>Public company</li></ul></td></tr><tr><th>Listing on the Exchange</th><td><ul><li>NYSE | LLY</li></ul></td></tr><tr><th>Founding</th><td><ul><li>1876</li></ul></td></tr><tr><th>Founders</th><td><ul><li>Ilai Lilly</li></ul></td></tr><tr><th>Location</th><td><ul><li>USA | : Indianapolis (Indiana)</li></ul></td></tr><tr><th>Key figures</th><td><ul><li>Dave Ricks (Chairman, President, CEO)</li></ul></td></tr><tr><th>Industry</th><td><ul><li>Pharmaceutical Industry</li></ul></td></tr><tr><th>Products</th><td><ul><li>medicine</li></ul></td></tr><tr><th>Equity</th><td><ul><li>▼ | $9,829 billion (2018)</li></ul></td></tr><tr><th>Collections</th><td><ul><li>▲ | $24,556 bn (2018)</li></ul></td></tr><tr><th>Net profit</th><td><ul><li>▲ | $3,232 billion (2018)</li></ul></td></tr><tr><th>Assets</th><td><ul><li>▲ | $43,908 billion (2018)</li></ul></td></tr><tr><th>Capitalization</th><td><ul><li>▲ | $225 billion | (11.12.2019)</li></ul></td></tr><tr><th>Number of employees</th><td><ul><li>38 350 (2018)</li></ul></td></tr><tr><th>Subsidiary companies</th><td><ul><li>Eli Lilly (United Kingdom) | [d] |, | Eli Lilly (Canada) | [d] |, | Eli Lilly (Germany) | [d] |, | Eli Lilly (Singapore) | [d] |, | Eli Lilly (India) | [d] |, | Lilly (China) | [d] |, | Eli Lilly (Italy) | [d] | and | Lilly France | [d]</li></ul></td></tr><tr><th>Auditor</th><td><ul><li>Ernst &amp; Young</li></ul></td></tr><tr><th>Website</th><td><ul><li>www.lilly.com</li></ul></td></tr></table>